SCHEMBL11076150

SCHEMBL11076150

CC(=O)CCn1cnc2c1c(=S)n(C)c(=O)n2C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 3/20 0.62
MAPK1 P28482 2/20 0.62
PDE4A P27815 3/20 0.56
PDE4B Q07343 2/20 0.56
PDE4C Q08493 2/20 0.56
PDE4D Q08499 2/20 0.56
ADORA2B P29275 9/20 0.55
LMNA P02545 4/20 0.53
MAPT P10636 2/20 0.53
CYP1A2 P05177 2/20 0.53
NFKB1 P19838 2/20 0.53
ACHE P22303 2/20 0.53
PMP22 Q01453 2/20 0.53
ESR1 P03372 1/20 0.53
BLM P54132 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.48
USP2 O75604 1/20 0.48
TNF P01375 1/20 0.48
TSHR P16473 1/20 0.48
TRPA1 O75762 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24559323 0.92 RXFP1 (0.70) RXFP1MAPK1PDE4APDE4BPDE4C
SCHEMBL11077091 0.87 ADORA2B (0.58) RXFP1MAPK1PDE4APDE4BPDE4C
SCHEMBL10967382 0.86 MAPK1 (0.82) RXFP1MAPK1PDE4APDE4BPDE4C
SCHEMBL24559396 0.84 ADORA2B (0.73) RXFP1MAPK1PDE4APDE4BPDE4C
SCHEMBL24559134 0.84 RXFP1 (0.56) RXFP1MAPK1PDE4AADORA2BLMNA
SCHEMBL24559132 0.83 TNF (0.59) RXFP1MAPK1ADORA2BLMNAMAPT
SCHEMBL24559298 0.82 ADORA2B (0.61) RXFP1MAPK1PDE4APDE4BPDE4C
SCHEMBL24559305 0.82 ADORA2B (0.74) RXFP1MAPK1ADORA2BLMNAMAPT
SCHEMBL24559089 0.79 ADORA2B (0.61) RXFP1MAPK1ADORA2BLMNAMAPT
SCHEMBL22521931 0.79 TNF (0.60) RXFP1MAPK1ADORA2BLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4454138-A TREATMENT OF VASCULAR DISEASES Wuelfing, Johann A. (DE) 1984-06-12 US disclosed
EP-0018136-A1 Xanthine derivatives, a process for their preparation and their use in pharmaceutical compositions BEECHAM - WUELFING GmbH & Co. KG (DE) 1980-10-29 EP disclosed